For: | Hogan DE, Ma M, Kadosh D, Menon A, Chin K, Swaminath A. Endo-hepatology: An emerging field. World J Gastrointest Endosc 2021; 13(8): 296-301 [PMID: 34512877 DOI: 10.4253/wjge.v13.i8.296] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i8/296.htm |
Number | Citing Articles |
1 |
Rui Gaspar, Guilherme Macedo. Non-Invasive versus Invasive Assessment of Portal Hypertension in Chronic Liver Disease. GE - Portuguese Journal of Gastroenterology 2024; : 1 doi: 10.1159/000538484
|
2 |
Sajid Jalil, Ashwani K. Singal. Non-Cirrhotic Portal Hypertension: an Overview. Current Hepatology Reports 2024; 23(1): 153 doi: 10.1007/s11901-024-00642-x
|
3 |
Vaneet Jearth, Sridhar Sundaram, Surinder Singh Rana. Diagnostic and interventional EUS in hepatology: An updated review. Endoscopic Ultrasound 2022; 11(5): 355 doi: 10.4103/EUS-D-22-00027
|
4 |
David L. Carr-Locke. ERCP: a very personal history. Clinical Liver Disease 2023; 22(6): 211 doi: 10.1097/CLD.0000000000000028
|
5 |
Tajana Pavic, Ivana Mikolasevic, Dominik Kralj, Nina Blazevic, Anita Skrtic, Ivan Budimir, Ivan Lerotic, Davor Hrabar. Role of Endoscopic Ultrasound in Liver Disease: Where Do We Stand?. Diagnostics 2021; 11(11): 2021 doi: 10.3390/diagnostics11112021
|
6 |
Wafaa Ahmed, Deepak Joshi, Matthew T Huggett, Simon M Everett, Martin James, Shyam Menon, Kofi W Oppong, Wei On, Bharat Paranandi, Palak Trivedi, George Webster, Vinod S Hegade. Update on the optimisation of endoscopic retrograde cholangiography (ERC) in patients with primary sclerosing cholangitis. Frontline Gastroenterology 2024; 15(1): 74 doi: 10.1136/flgastro-2023-102491
|
7 |
Varun Aitharaju, Jonathan Ragheb, Stephen Firkins, Roma Patel, C. Roberto Simons-Linares. Endoscopic bariatric and metabolic therapies and its effect on metabolic dysfunction-associated steatotic liver disease: a review of the current literature. Surgery for Obesity and Related Diseases 2024; doi: 10.1016/j.soard.2024.09.012
|